Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bekalu Amare Tesfaye, Haftom Gebregergs Hailu, Kaleab Alemayehu Zewdie, Muluken Altaye Ayza & Derbew Fikadu Berhe. (2021) Montelukast: The New Therapeutic Option for the Treatment of Epilepsy. Journal of Experimental Pharmacology 13, pages 23-31.
Read now
Read now
Articles from other publishers (35)
Giulia Magni, Benedetta Riboldi & Stefania Ceruti. (2024) Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies. Cells 13:7, pages 606.
Crossref
Crossref
Surbhi Gupta, Prabhat Singh & Bhupesh Sharma. (2024) Montelukast Ameliorates 2K1C-Hypertension Induced Endothelial
Dysfunction and Associated Vascular Dementia. Current Hypertension Reviews 20:1, pages 23-35.
Crossref
Crossref
Min-Lan Tsai, Hsiu-Chen Lin, Chiung-Hui Yen, Jung-Tzu Ku, Shian-Ying Sung & Hsi Chang. (2022) Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study. Children 9:11, pages 1607.
Crossref
Crossref
Atefeh Mohammadi, Randa Higazy & Estelle B. Gauda. (2022) PGC-1α activity and mitochondrial dysfunction in preterm infants. Frontiers in Physiology 13.
Crossref
Crossref
Sahithi Attaluri, Raghavendra Upadhya, Maheedhar Kodali, Leelavathi N. Madhu, Dinesh Upadhya, Bing Shuai & Ashok K. Shetty. (2022) Brain-Specific Increase in Leukotriene Signaling Accompanies Chronic Neuroinflammation and Cognitive Impairment in a Model of Gulf War Illness. Frontiers in Immunology 13.
Crossref
Crossref
Sang Oh Kang, Kyung Hyun Min, Hyun Jeong Kim, Tae Hyeok Kim, Woorim Kim & Kyung Eun Lee. (2021) The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study. Asthma Research and Practice 7:1.
Crossref
Crossref
Johanna Michael, Julia Zirknitzer, Michael Stefan Unger, Rodolphe Poupardin, Tanja Rieß, Nadine Paiement, Horst Zerbe, Birgit Hutter-Paier, Herbert Reitsamer & Ludwig Aigner. (2021) The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice. International Journal of Molecular Sciences 22:5, pages 2782.
Crossref
Crossref
M. Hoxha, V. Malaj, M. Vara-Messler, C.R. Doce & A.B. Cavanillas. (2021) A case–control study: Evaluating the role of leukotriene receptor antagonists in preventing the cardiovascular and cerebrovascular disease. Medicina de Familia. SEMERGEN 47:1, pages 4-11.
Crossref
Crossref
J. Michael, M. S. Unger, R. Poupardin, P. Schernthaner, H. Mrowetz, J. Attems & L. Aigner. (2020) Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s Disease mice. Acta Neuropathologica Communications 8:1.
Crossref
Crossref
Yu-Ting Tseng, Tynan M. Cox, Gary D. Grant, Devinder Arora, Susan Hall, Amelia J. McFarland, Jenny Ekberg, Santosh Rudrawar & Shailendra Anoopkumar-Dukie. (2020) In vitro cytotoxicity of montelukast in HAPI and SH-SY5Y cells. Chemico-Biological Interactions 326, pages 109134.
Crossref
Crossref
Li Zhou, Xiaomin Sun, Yong Shi, Junpeng Liu, Guohui Luan & Yanwen Yang. (2019) Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood–brain barrier. Inflammopharmacology 27:5, pages 933-940.
Crossref
Crossref
Colleen N. BodnarKelly N. RobertsEmma K. HigginsAdam D. Bachstetter. (2019) A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats. Journal of Neurotrauma 36:11, pages 1683-1706.
Crossref
Crossref
Johanna Michael, Julia Marschallinger & Ludwig Aigner. (2019) The leukotriene signaling pathway: a druggable target in Alzheimer’s disease. Drug Discovery Today 24:2, pages 505-516.
Crossref
Crossref
Hale Z. Toklu, Zhiui Yang, Mehmet Ersahin & Kevin K. W. Wang. 2019. Psychiatric Disorders. Psychiatric Disorders
371
381
.
Adel El-shafaei, Rania Abdelmaksoud, Amany Elshorbagy, Noha Zahran & Rana Elabd. (2018) Protective effect of melatonin versus montelukast in cisplatin-induced seminiferous tubule damage in rats. Andrologia 50:9, pages e13077.
Crossref
Crossref
Malvina Hoxha, Anne-Mary Lewis-Mikhael & Aurora Bueno-Cavanillas. (2018) Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies. Biomedicine & Pharmacotherapy 106, pages 956-965.
Crossref
Crossref
Peter A. Noshy, Mohamed A. Elhady, Abdel Azeim A. Khalaf, Mervat M. Kamel & Eman I. Hassanen. (2018) Ameliorative effect of carvacrol against propiconazole-induced neurobehavioral toxicity in rats. NeuroToxicology 67, pages 141-149.
Crossref
Crossref
Hale Z. Toklu, Zhihui Yang, Sehkar Oktay, Yasemin Sakarya, Nataliya Kirichenko, Michael K. Matheny, Judy Muller-Delp, Kevin Strang, Philip J. Scarpace, Kevin K.W. Wang & Nihal Tümer. (2018) Overpressure blast injury-induced oxidative stress and neuroinflammation response in rat frontal cortex and cerebellum. Behavioural Brain Research 340, pages 14-22.
Crossref
Crossref
Faiza Khalid, Awais Aftab & Sumita Khatri. (2018) The Association Between Leukotriene-Modifying Agents and Suicidality: A Review of Literature. Psychosomatics 59:1, pages 19-27.
Crossref
Crossref
Meindina G. Haarman, Florence van Hunsel & Tjalling W. de Vries. (2017) Adverse drug reactions of montelukast in children and adults. Pharmacology Research & Perspectives 5:5.
Crossref
Crossref
Malvina Hoxha, G. Enrico Rovati & Aurora Bueno Cavanillas. (2017) The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. European Journal of Clinical Pharmacology 73:7, pages 799-809.
Crossref
Crossref
K.A. Heidenreich & C.E. Corser-Jensen. 2017. New Therapeutics for Traumatic Brain Injury. New Therapeutics for Traumatic Brain Injury
199
210
.
Hale Z Toklu, Judy Muller-Delp, Zhihui Yang, Şehkar Oktay, Yasemin Sakarya, Kevin Strang, Payal Ghosh, Michael D Delp, Philip J Scarpace, Kevin KW Wang & Nihal Tümer. (2015) The Functional and Structural Changes in the Basilar Artery Due to Overpressure Blast Injury. Journal of Cerebral Blood Flow & Metabolism 35:12, pages 1950-1956.
Crossref
Crossref
X. Tao, X. Chen, S. Hao, Z. Hou, T. Lu, M. Sun & B. Liu. (2015) Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood–brain barrier after traumatic brain injury in mice. Neuroscience 291, pages 26-36.
Crossref
Crossref
Oytun Erbas. (2015) Montelukast Inhibits Pentylenetetrazol-Induced Seizures in Rats. Medical Science Monitor 21, pages 869-874.
Crossref
Crossref
Q.F. Lenz, D.S. Arroyo, F.R. Temp, A.B. Poersch, C.J. Masson, A.C. Jesse, J.R. Marafiga, C.R. Reschke, P. Iribarren & C.F. Mello. (2014) Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood–brain barrier dysfunction. Neuroscience 277, pages 859-871.
Crossref
Crossref
Chelsea E. Corser-Jensen, Dayton J. Goodell, Ronald K. Freund, Predrag Serbedzija, Robert C. Murphy, Santiago E. Farias, Mark L. Dell'Acqua, Lauren C. Frey, Natalie Serkova & Kim A. Heidenreich. (2014) Blocking leukotriene synthesis attenuates the pathophysiology of traumatic brain injury and associated cognitive deficits. Experimental Neurology 256, pages 7-16.
Crossref
Crossref
Hasan Demir, Ozge E. Onur, Arzu Denizbasi, Haldun Akoglu, Serkan E. Eroglu, Cigdem Ozpolat & Ebru Akoglu. (2013) The effects of adrenomedullin in traumatic brain injury. Peptides 43, pages 27-31.
Crossref
Crossref
Valérie Capra, Magnus Bäck, Silvia S. Barbieri, Marina Camera, Elena Tremoli & G. Enrico Rovati. (2012) Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke. Medicinal Research Reviews 33:2, pages 364-438.
Crossref
Crossref
Ellinor Kenne, Anna Erlandsson, Lennart Lindbom, Lars Hillered & Fredrik Clausen. (2012) Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice. Journal of Neuroinflammation 9:1.
Crossref
Crossref
Muslim M. Al Saadi, Sultan Ayoub Meo, Ali Mustafa, Ahmed Shafi & Ali S. Al Tuwajri. (2011) Effects of Montelukast on free radical production in whole blood and isolated human polymorphonuclear neutrophils (PMNs) in asthmatic children. Saudi Pharmaceutical Journal 19:4, pages 215-220.
Crossref
Crossref
Magnus Bäck, Sven-Erik Dahlén, Jeffrey M. Drazen, Jilly F. Evans, Charles N. Serhan, Takao Shimizu, Takehiko Yokomizo & G. Enrico Rovati. (2011) International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions. Pharmacological Reviews 63:3, pages 539-584.
Crossref
Crossref
Glen T. Schumock, Todd A. Lee, Min J. Joo, Robert J. Valuck, Leslie T. Stayner & Robert D. Gibbons. (2011) Association between Leukotriene-Modifying Agents and Suicide. Drug Safety 34:7, pages 533-544.
Crossref
Crossref
Michael Frink, Hagen Andruszkow, Christian Zeckey, Christian Krettek & Frank Hildebrand. (2011) Experimental Trauma Models: An Update. Journal of Biomedicine and Biotechnology 2011, pages 1-15.
Crossref
Crossref
H. Kalonia, P. Kumar, A. Kumar & B. Nehru. (2010) Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats. Neuroscience 171:1, pages 284-299.
Crossref
Crossref